Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT)

American Heart Journal

Volumn 144, Issue 2, 2002, Pages 219-225

  Van Den Brink, Rob H S ^a   Van Melle, Joost P ^b   Honig, Adriaan ^d   Schene, Aart H ^e   Crijns, Harry J G M ^b,d   Lambert, Frank P G ^c   Ormel, Johan ^a  

^a Graduate School of Behavioral and Cognitive Neurosciences   (Netherlands)

^b Thoraxcenter   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC TREATMENT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOMATOLOGY; UNSTABLE ANGINA PECTORIS;

EID: 0036347945     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjh.2002.123580     Document Type: Article

References (54)

1. Mortality among patients with involutional melancholia
2. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults
3. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
4. Depression as an antecedent to heart disease among women and men in the NHANES I study
5. Depression and cardiac mortality: Results from a community-based longitudinal study
6. Major depressive disorder predicts cardiac events in patients with coronary artery disease
7. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: A two-years follow-up study
8. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk study
9. Depression and 1-year prognosis in unstable angina
10. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)
11. Affective disorders and survival after acute ḿyocardial infarction: Results from the post-infarction late potential study
12. Depression following myocardial infarction: Impact on 6-month survival
13. Depression and 18-month prognosis after myocardial infarction
14. Personality and mortality after myocardial infarction
15. The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression?
16. The nature and course of depression following myocardial infarction
17. Depression following myocardial infarction
18. Major depression before and after myocardial infarction: Its nature and consequences
19. Depressie na een eerste hartinfarct; overeenkomsten en verschillen met 'gewone' depressie
20. Psychoimmunology as a common pathogenic pathway in myocardial infarction, depression and cardiac death
21. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease
22. Perspectives on the relationship between cardiovascular disease and affective disorder
23. Association of depression with reduced heart rate variability in coronary artery disease
24. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease
25. Exaggerated platelet reactivity in major depression
26. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease
27. Psychological factors associated with maintenance of improved health behaviors in postcoronary patients
28. Major depression and medication adherence in elderly patients with coronary artery disease
29. Post-infarction depression and incomplete recovery 6 months arter acute myocardial infarction
30. Depression following myocardial infarction: A one year longitudinal study
31. Depression and chronic medical illness
32. Underdiagnosis of depression in patients with coronary artery disease: The role of nonspecific symptoms
33. Depression and acute myocardial infarction: A review and reinterpretation
34. Review of psychosomatic aspects of cardiovascular disease
35. The safety of tricyclic antidepressants in cardiac patients: Risk-benefit reconsidered
36. Depression: The sleeping giant
37. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
38. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind placebo-controlled trial
39. An open label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT trial)
40. Can treating depression reduce mortality after an acute myocardial infarction?
41. A randomized double-blind placebo controlled trial of the selective serotonin reuptake inhibitor (SSRI) sertraline for major depression after acute coronary syndromes (ACS): The SADHART Trial
42. Enhancing recovery in coronary heart disease patients (ENRICHD): Study design and methods
43. The effect of treating depression and low social support on clinical events after a myocardial infarction
44. Safety of mirtazapine: A review
45. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission
46. Mirtazapine. A review of its use in major depression
47. Clinical efficacy of mirtazapine: A review of meta-analyses of pooled data
48. The Hamilton rating scale for depression
49. Pharmacological characterization of selective seratonin reuptake inhibitors (SSRIs)
50. The antidepressant efficacy of citalopram
51. Treatment of depression in elderly patients with and without dementia disorders